BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, ...

北卡罗来纳州研究三角园 - 市值17.2亿美元、年收入5.0349亿美元的生物技术公司BioCryst制药公司 (NASDAQ: BCRX )周四宣布，总裁兼首席执行官Jon Stonehouse将于2025年12月31日退休，在他的领导下公司已实现商业盈利。根据 InvestingPro 数据，该公司在过去十二个月内实现了41.67%的显著收入增长。

BioCryst Pharmaceuticals' president and chief executive, Jon Stonehouse, plans to retire from the biotechnology company at the end of the year. BioCryst on Thursday said Charlie Gayer, who has been ...

BioCryst Pharmaceuticals (NASDAQ:BCRX) said that Chief Executive Officer Jon Stonehouse will retire on December 31. The board has appointed Charlie Gayer, currently the company’s chief commercial ...

Since Season 17 of RuPaul's Drag Race was dubbed the "splashiest season in herstory," it only made sense for its 2025 Emmys campaign event to be a pool party. The top six queens — winner Onya ...

Michał Gayer’s practice is a consequence of an insightful observation of the reality and transformations of selected phenomena, events or situations into multilayered narratives, often ...